When.com Web Search

  1. Ads

    related to: latest eye drops for glaucoma list of symptoms

Search results

  1. Results From The WOW.Com Content Network
  2. A Full List of Recalled Eye Drops Linked to Potential ... - AOL

    www.aol.com/full-list-recalled-eye-drops...

    Brimonidine Tartrate Ophthalmic Solution, 0.15%: A special tool designated for those with glaucoma or ocular hypertension, a small subset of these eye drops are being voluntarily recalled as ...

  3. Eyedrops for glaucoma, ocular hypertension recalled ...

    www.aol.com/eyedrops-glaucoma-ocular...

    Cracks begun to form in these eye drop bottles sold nationwide that may impact sterility and cause “adverse events”. Eyedrops for glaucoma, ocular hypertension recalled nationally by Broward ...

  4. Glaucoma medication - Wikipedia

    en.wikipedia.org/wiki/Glaucoma_medication

    Glaucoma medication is divided into groups based on chemical structure and pharmacologic action. The goal of currently available glaucoma therapy is to preserve visual function by lowering intraocular pressure (IOP) in patients that have an increased intraocular pressure.

  5. Dorzolamide/timolol - Wikipedia

    en.wikipedia.org/wiki/Dorzolamide/timolol

    Dorzolamide/timolol, sold under the brand name Cosopt among others, is a medication used to treat high pressure inside the eye including glaucoma. [3] [5] [6] It is a combination of dorzolamide hydrochloride and timolol maleate. [3] It may be used when a beta blocker, like timolol, is not sufficient alone. [7] It is used as an eye drop. [3]

  6. The FDA Has Issued Another Warning About Eye Drops - AOL

    www.aol.com/full-list-recalled-eye-drops...

    LightEyez MSM Eye Drops-Eye Repair, NDC number not provided. CVS Health Lubricant Eye Drops 15 ml (single pack) , NDC number 76168-702-15. CVS Health Lubricant Eye Drops 15 ml (twin pack) , NDC ...

  7. Omidenepag - Wikipedia

    en.wikipedia.org/wiki/Omidenepag

    Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension. [ 1 ] [ 3 ] Omidenepag was approved for medical use in Japan in 2018, [ 3 ] and in the United States in September 2022.